Researchers closer to understanding how proteins regulate immune system

July 3, 2012

Researchers in the biological sciences department in the Faculty of Science at the University of Calgary have revealed how white blood cells move to infection or inflammation in the body; findings which could help lead to developing drug therapies for immune system disorders. The research is published this month in the Journal of Biological Chemistry.

It's long been known that two human proteins—L-selectin and calmodulin—are involved in moving white blood cells to the site of inflammation or infection in the body. L-selectin is embedded in the cellular membrane of the white and acts like Velcro, tethering the white blood cell to the sticky surface on the wall of the blood vessel.

When the white blood cell reaches a site of infection or inflammation, it 'sheds' the L-selectin protein, which lets it leave the blood stream and enter the damaged tissue. This shedding process is controlled inside of the white blood cell by the protein calmodulin.

"Cell biologists had figured out in 1998 that calmodulin was negatively regulating the shedding process of L-selectin," says Jessica Gifford, a PhD student supervised by Hans Vogel. "They knew calmodulin did it, but they didn't know how."

Using powerful magnets and a technique called nuclear magnetic resonance (NMR) spectroscopy, Gifford and Vogel determined the molecular structure of the interaction between the two proteins, providing important insight at the molecular level into how calmodulin controls the shedding of L-selectin.

"Understanding the molecular details of these processes will help us understand how our bodies respond to ," says Gifford, "and if we can understand that, that's the first step of producing drug therapies to manipulate your , to either turn it on, or turn it off."

There is a growing interest in to help regulate the immune system, say GIfford. "So many problems that people have are due to overactive immune systems," she says. "By understanding how your get around, then maybe we can stop them from getting there when they don't need to be."

Explore further: Study reveals new form of inflammation

More information: The paper, entitled "Structural Insights into Calmodulin-Regulated L-Selectin Shedding" is available as a Paper in Press on the Journal of Biological Chemistry website.

Related Stories

Study reveals new form of inflammation

May 16, 2011
(Medical Xpress) -- University of Edinburgh scientists have discovered a previously unknown way in which white blood cells cope with injury and infection.

Solving the mystery of blood clotting

March 19, 2012
How and when our blood clots is one of those incredibly complex and important processes in our body that we rarely think about. If your blood doesn't clot and you cut yourself, you could bleed to death, if your blood clots ...

Recommended for you

Exposure to larger air particles linked to increased risk of asthma in children

December 15, 2017
Researchers at The Johns Hopkins University report statistical evidence that children exposed to airborne coarse particulate matter—a mix of dust, sand and non-exhaust tailpipe emissions, such as tire rubber—are more ...

Bioengineers imagine the future of vaccines and immunotherapy

December 14, 2017
In the not-too-distant future, nanoparticles delivered to a cancer patient's immune cells might teach the cells to destroy tumors. A flu vaccine might look and feel like applying a small, round Band-Aid to your skin.

Immune cells turn back time to achieve memory

December 13, 2017
Memory T cells earn their name by embodying the memory of the immune system - they help the body remember what infections or vaccines someone has been exposed to. But to become memory T cells, the cells go backwards in time, ...

Steroid study sheds light on long term side effects of medicines

December 13, 2017
Fresh insights into key hormones found in commonly prescribed medicines have been discovered, providing further understanding of the medicines' side effects.

The immune cells that help tumors instead of destroying them

December 12, 2017
Lung cancer is the leading cause of cancer-associated deaths. One of the most promising ways to treat it is by immunotherapy, a strategy that turns the patient's immune system against the tumor. In the past twenty years, ...

Cancer gene plays key role in cystic fibrosis lung infections

December 12, 2017
PTEN is best known as a tumor suppressor, a type of protein that protects cells from growing uncontrollably and becoming cancerous. But according to a new study from Columbia University Medical Center (CUMC), PTEN has a second, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.